Verweij et al. initiated a genome-wide association study on plasma levels of midregional proadrenomedullin and C-terminal-pro-ET-1 (CT-pro-ET-1) (a biologically stable surrogate for ET-1), which at high levels are predictors of heart disease and heart failure [71]. This evidence concerns the gene EDN1 and heart failure.